BRIAN A MARKISON Insider Trading $KG KING PHARMACEUTICALS INC
Get free email notifications about insider trading for BRIAN A MARKISON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRIAN A MARKISON. BRIAN A MARKISON is Director in IMMUNOMEDICS INC ($IMMU) and Chief Operating Officer in KING PHARMACEUTICALS INC ($KG) and President & CEO in KING PHARMACEUTICALS INC ($KG) and President and CEO in KING PHARMACEUTICALS INC ($KG) and Director in ALERE INC. ($ALR) and Director in Lantheus Holdings, Inc. ($LNTH) and in Avista Healthcare Public Acquisition Corp. ($AHPA) and Director in Avista Healthcare Public Acquisition Corp. ($AHPA) and Chief Executive Officer in Osmotica Pharmaceuticals plc ($OSMT).
BRIAN A MARKISON in KING PHARMACEUTICALS INC
Trading Symbol: KGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BRIAN A MARKISON: President and CEO, President & CEO, Chief Operating Officer
Holdings: 0 shares
Latest Transaction: Feb 02 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BRIAN A MARKISON in KING PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALR, IMMU, KG, LNTH, ORGO, OSMT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 12.44 | 225,130 | 2,800,617 | 0 | |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 6.97 | 250,970 | 1,749,261 | 0 | |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 8.91 | 181,590 | 1,617,967 | 0 | |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 10.57 | 250,000 | 2,642,500 | 0 | |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | D | 0.00 | 95,213 | 0 | 0 | |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | D | 0.00 | 278,160 | 0 | 0 | |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Sell | D | 0.00 | 200,760 | 0 | 0 | 200.8 K to 0 (-100.00 %) |
Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Sell | U | 0.00 | 547,360 | 0 | 200,760 | 748.1 K to 200.8 K (-73.16 %) |
Jan 20 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 95,213 | 0 | 95,213 | |
Jan 20 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | M | 0.00 | 201,260 | 0 | 0 | |
Jan 20 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Buy | M | 0.00 | 201,260 | 0 | 748,120 | 546.9 K to 748.1 K (+36.80 %) |
Jan 11 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 86,260 | 0 | 546,860 | 460.6 K to 546.9 K (+18.73 %) |
Dec 17 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 14.22 | 92,700 | 1,318,194 | 460,600 | 553.3 K to 460.6 K (-16.75 %) |
Mar 24 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 12.25 | 21,706 | 265,899 | 561,484 | 583.2 K to 561.5 K (-3.72 %) |
Mar 19 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 12.44 | 225,130 | 2,800,617 | 225,130 | |
Mar 19 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 63,790 | 0 | 583,190 | 519.4 K to 583.2 K (+12.28 %) |
Mar 12 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 12.22 | 42,246 | 516,246 | 519,400 | 561.6 K to 519.4 K (-7.52 %) |
Mar 04 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Sell | S | 11.72 | 69,744 | 817,679 | 561,646 | 631.4 K to 561.6 K (-11.05 %) |
Mar 01 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 278,160 | 0 | 278,160 | |
Jan 05 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | M | 0.00 | 108,801 | 0 | 0 | |
Jan 05 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Buy | M | 0.00 | 108,801 | 0 | 631,390 | 522.6 K to 631.4 K (+20.82 %) |
Mar 25 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 6.97 | 250,970 | 1,749,261 | 250,970 | |
Mar 25 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 79,470 | 0 | 522,589 | 443.1 K to 522.6 K (+17.93 %) |
Mar 24 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 6.80 | 9,979 | 67,857 | 443,119 | 453.1 K to 443.1 K (-2.20 %) |
Mar 12 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 6.31 | 29,454 | 185,855 | 453,098 | 482.6 K to 453.1 K (-6.10 %) |
Feb 19 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 201,260 | 0 | 201,260 | |
Jan 21 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | M | 0.00 | 68,580 | 0 | 0 | |
Jan 21 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 12,448 | 0 | 482,552 | 470.1 K to 482.6 K (+2.65 %) |
Jan 21 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Buy | M | 0.00 | 68,580 | 0 | 470,104 | 401.5 K to 470.1 K (+17.08 %) |
Sep 02 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 10.15 | 60,256 | 611,598 | 401,524 | 461.8 K to 401.5 K (-13.05 %) |
Mar 27 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 8.91 | 181,590 | 1,617,967 | 181,590 | |
Mar 27 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 57,500 | 0 | 461,780 | 404.3 K to 461.8 K (+14.22 %) |
Feb 22 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 108,801 | 0 | 108,801 | |
Dec 18 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 404,280 | 204.3 K to 404.3 K (+97.90 %) |
Mar 23 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 19.29 | 92,110 | 1,776,802 | 92,110 | |
Mar 23 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 46,830 | 0 | 204,280 | 157.5 K to 204.3 K (+29.74 %) |
Feb 28 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 68,580 | 0 | 68,580 | |
Mar 22 2006 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 19.68 | 53,980 | 1,062,326 | 53,980 | |
Mar 22 2006 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 27,450 | 0 | 157,450 | 130 K to 157.5 K (+21.12 %) |
Oct 20 2005 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 130,000 | 0 | 130,000 | 0 to 130 K |
Jul 16 2004 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President & CEO | Option Exercise | A | 10.67 | 250,000 | 2,667,500 | 250,000 | |
Mar 09 2004 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | Chief Operating Off ... | Option Exercise | A | 19.47 | 125,000 | 2,433,750 | 125,000 | |
Mar 09 2004 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | Chief Operating Off ... | Option Exercise | A | 19.47 | 125,000 | 2,433,750 | 125,000 |
Page: 1